Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma-Reference-Cited by-同舟云学术

Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma

Published:2019-05-10 Issue:1 Volume:47 Page:1908-1916
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Yin Li¹,He Na¹,Chen Chuizhe¹,Zhang Nan¹,Lin Yingzi¹,Xia Qianfeng¹

Affiliation:

1. Laboratory of Tropical Biomedicine and Biotechnology, School of Tropical Medicine and Laboratory Medicine, Hainan Medical University, Haikou, Hainan, China

Funder

National Key R&D Program of China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://tandfonline.com/doi/pdf/10.1080/21691401.2019.1613421

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Hepatitis C virus and hepatocarcinogenesis

3. Hepatitis C Virus–Associated Cancer

4. Challenges to Liver Transplantation and Strategies to Improve Outcomes

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma;Scientific Reports;2024-03-29

2. Bioinformatic Analysis and Computer-Aided Study to Investigate the Potential Application of a Bioflavonoid Compound Bilobetin in Liver Cancer Treatment;Frontiers in Bioscience-Landmark;2023-12-29

3. Integrated analysis of tumour-derived exosome-related immune genes to predict progression and immune status of hepatocellular carcinoma;Clinical Immunology;2023-11

4. A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach;Metabolites;2023-10-30

5. Artificial intelligence using multiomics/genetic tools and application in liver disease;Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases;2023